Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

What is the optimal therapeutic approach following progression on front line PARP inhibitor maintenance therapy in ovarian cancer?

The role of surgery

Date

23 Oct 2023

Session

What is the optimal therapeutic approach following progression on front line PARP inhibitor maintenance therapy in ovarian cancer?

Topics

Radiological Imaging;  Targeted Therapy;  Surgical Oncology;  Survivorship

Tumour Site

Ovarian Cancer

Presenters

Sven Mahner

Authors

S. Mahner

Author affiliations

  • Department Of Obstetrics And Gynecology, University Hospital, LMU Munich, 81377 - München/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Presentation of case/condition

Presenter: Antonio Gonzalez Martin

Session: What is the optimal therapeutic approach following progression on front line PARP inhibitor maintenance therapy in ovarian cancer?

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: What is the optimal therapeutic approach following progression on front line PARP inhibitor maintenance therapy in ovarian cancer?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.